ISSN 1673-5765 CN 11-5434/R
Morality and Ethics
Section 1 Ethics for Authors
1. Plagiarism: All manuscripts would be tested by the plagiarism checking system developed by CNKI and WANFANG. The repetition rate should be less than 15%. Authors, reviewers and editors should avoid academic misconduct defined in Academic Publishing Specification-Definition of Academic Misconduct for Journals (CY/T 174-2019). Once academic misconduct is found, the journal will make a retraction statement. Reviewers and editors involved in academic misconduct will be deprived of their reviewer qualifications. If the authors want to submit the article to another journal, please contact our journal first. Multiple submission is strictly prohibited. Once multiple submission is confirmed, the manuscript will be rejected. If the article has been published in our journal, we will make a statement about the repeated publication of the article, inform the author's institute and other scientific and technological journals in the field. For situations mentioned above, the journal will reject all manuscripts of which the punished ones serve as authors within 2 years.
2. Authorship：Those who are named as authors should directly participate in the research and writing work and should be responsible for the manuscript. “Gift author” is strictly prohibited. If there is any non-Chinese citizen among authors, a letter of consent for publishing should be obtained. The author's signature is arranged in order of contribution under the title. The order of authors shall be collectively determined before submission and shall not be changed thereafter. If truly necessary, the order could be changed if a statement signed by all authors is provided. There should be only one corresponding author. If a group is indicated, the institutes and the names of the members should be listed before the references at the end of the article. The authors should specify their contribution in the Authors Contribution Form and submit it along with the manuscript.
3. Medical Ethics: The ethical issue of the study must comply with common principles of medical ethics. When research participants are humans, the author should explain whether the procedure complied with the ethical standards formulated by the relevant committee (institutional, regional or national) responsible for human trials. The approval document of the committee should be submitted. Consent letters from research participants or their relatives must be obtained but not submitted to the editorial office. When reporting animal experiments, the study should comply with guidelines published by the relevant committee on animal rights, and the approval document should be submitted.
4. Trial Registration: Clinical trials must include the Universal Trial Number (UTN) obtained from one of the Primary Registries in the WHO Registry Network. The UTN shall be included in the abstract or the main body of the full text.
5. Conflicts of Interest: All authors must disclose all potential conflicts of interest, i.e., when the financing/ personal status/ affiliation of the authors (or the authors' organization/ employer) may affect the authors' decision, work or manuscript. When a product is involved, the author should also disclose whether there is a conflict of interest against competitive products. Authors should also submit the Statement of Competing Interests along with the manuscript.
Section 2 Ethics for Editors and Reviewers
1. Impartiality: Editors and reviewers shall treat all manuscripts with professional attitude to make the review process transparent, confidential and fair. They should accept or evaluate manuscripts for their intellectual content without bias towards race, gender, religious belief, citizenship, or nationality of authors. Publishers and editors should always be ready to publish corrections, clarifications, retractions and apologies when needed.
2. Confidentiality: Editors and reviewers must keep confidential of the manuscripts under review, not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, and the publisher. They should not use unpublished papers or materials in their research.
3. Avoidance of Misconduct: Editors and reviewers should take reasonable steps to identify and prevent the publication of papers involving academic misconduct. They would not encourage such academic misconduct, or knowingly allow such misconduct to take place. Once the reviewers find that there are mistakes, plagiarism, suspected forgery of data and other problems in the article, they are obliged to report it to the editorial office. The editorial office would take appropriate action if there is any allegation of research misconduct.
4. Conflict of Interest: If Editors or reviewers have competition, collaboration or other relations with the author, company or institution related to the article, they should report the conflict of interest and avoid reviewing the article if necessary.
Section 3 Commercial Mode
Chinese Journal of Stroke is an open access journal. The journal is financed by article processing fees, subscriptions fees for print edition, and advertisement. The review and acceptance of manuscripts are not influenced by commercial considerations.
Section 4 Intellectual Property Protection
The editorial department respects the protection of intellectual property rights and requires editors, authors and reviewers to do so. Any possible infringement should be avoided. Third-party organizations must also respect the intellectual property rights of the journal and refrain from infringement.